Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Ageless vs RedBox Rx

Ageless
Graded #10

Higher grade

vs+14.599999999999994
RedBox Rx
Graded #111

Lower grade

The verdict

Ageless takes it — 84.8/100 to 70.2/100.

Ageless grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. One of the broadest compounded storefronts on the board — GLP-1, NAD+, sermorelin, TRT and more under one roof, in both injectable and oral routes, on low headline pricing (semaglutide $119/mo, tirzepatide $169/mo) — offset by a compounded-only catalog and an undisclosed state list.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAgeless +48
90
42
Dose & formulationAgeless +7
90
83
Clinical oversightRedBox Rx +13
80
93
Labs & monitoringRedBox Rx +6
78
84
FulfillmentAgeless +12
84
72
Contract termsAgeless +41
82
41
Ageless · left barRedBox Rx · right bar

The numbers

MetricAgelessRedBox Rx
WeighScore84.8/10070.2/100
GradeBC
Scorecard rank#10#111
Semaglutide$119/mo$269/mo (all doses, 6-month plan, compounded)
Tirzepatide$169/mo$429/mo
CoverageVaries by stateCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesYes
Ageless

Graded #10 · B

Strengths

  • Unusually broad compounded menu — GLP-1, NAD+, sermorelin, TRT, LDN and more, in both injectable and oral formats
  • Low headline GLP-1 pricing — semaglutide $119/mo, tirzepatide $169/mo — no insurance, with Klarna/Affirm financing
  • Fully online: licensed-clinician review and discreet delivery, with upfront compounded/not-FDA disclosures
  • Oral routes available (drops and troches), not injection-only

Where it loses points

  • Everything is compounded and not FDA-approved — not equivalent to brand Wegovy/Ozempic/Zepbound
  • Oral GLP-1 drops and troches lack robust absorption/efficacy evidence versus injectables
  • No published state-availability list and no named legal entity or medical group
  • Thin public track record, and advertised prices are floors set after clinical review
RedBox Rx

Graded #111 · C

Strengths

  • Flat, dose-independent pricing on both semaglutide and tirzepatide
  • Offers both weekly injections and daily oral tablets
  • Includes unlimited provider follow-ups, a metabolic panel and a dietitian session
  • Backed by grocery-pharmacy parent company Hy-Vee

Where it loses points

  • Does not serve every state (for example Mississippi is excluded)
  • Does not publicly name its compounding pharmacy

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard